OBJECTIVE: To identify prognostic metabolic and hormonal markers for l
ong-term weight loss outcome in obese women. DESIGN: Dietary intervent
ion consisting of 36 weeks treatment by a 4.2 MJ/d low-fat high carboh
ydrate diet, and follow-up 2 1/2 years after termination of treatment.
SETTING: Outpatient clinic in Copenhagen. SUBJECTS: Forty consecutive
female obese patients aged 15 to 62 years. MAIN OUTCOME MEASURE: Weig
ht loss. RESULTS: The maximum weight loss (mean 16.2 kg, 95% CI 14.2-1
8.2) was positively associated to pre-treatment 24-h energy expenditur
e (P < 0.01), fat oxidation (%) (P < 0.02), plasma dihydrotestosterone
(DHT) (P < 0.01), and to postprandial noradrenaline concentration (P
< 0.04). Together these factors could explain 41% of the variation in
maximum weight loss. Only 24-h EE and DHT had predictive power on weig
ht loss after 36 weeks. Weight losses in upper and lower tertiles of D
HT concentrations were 17.7 kg (14.1-21.4) and 9.8 kg (6.2-13.3) (P <
0.02). The adjusted relative risk of losing < 10 kg in the upper compa
red to the lower DHT tertile was 12% (4-32%). At 2 1/2 follow-up 21 pa
tients had maintained some of the weight loss (54%), while 14 patients
had maintained > 5 kg weight loss (36%). High levels of pre-treatment
DHT were also associated with better weight loss at 2 1/2 y follow-up
. CONCLUSION: The study suggests that in particular DHT, but also 24-h
EE, fat oxidation, and plasma noradrenaline, may be prognostic marker
s for weight loss outcome in obese women.